Matthew J Koster Selected Research

Matthew J Koster Research Topics

9	Vasculitis (Vasculitides) 06/2022 - 01/2017
8	Giant Cell Arteritis (Horton Disease) 01/2022 - 05/2016
5	VEXAS syndrome 03/2022 - 10/2021
3	Erdheim-Chester Disease 01/2022 - 11/2018
3	Neoplasms (Cancer) 01/2022 - 01/2019
2	Diplopia (Double Vision) 01/2022 - 05/2020
2	Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis) 01/2022 - 01/2021
2	Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell) 01/2021 - 12/2020
2	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2021 - 01/2016
1	Aneurysm (Aneurysms) 01/2022
1	Aortitis 01/2022
1	Fatigue 01/2022
1	Hemorrhage 01/2022
1	Infections 01/2022
1	Inflammation (Inflammations) 01/2022
1	Ischemia 01/2022
1	Nausea 01/2022
1	Multiple Myeloma 10/2021
1	Pleurisy (Pleuritis) 01/2021
1	Churg-Strauss Syndrome (Allergic Angiitis) 01/2021
1	Pericarditis 01/2021
1	Paresthesia (Dysesthesia) 05/2020
1	Headache (Headaches) 05/2020
1	Dermatomyositis (Dermatopolymyositis) 03/2020
1	Rheumatoid Vasculitis 01/2020
1	Hypertension (High Blood Pressure) 11/2017
1	Ankylosing Spondylitis 07/2017
1	Takayasu Arteritis (Arteritis, Takayasu's) 05/2016
1	Polyostotic Fibrous Dysplasia (McCune Albright Syndrome) 07/2006

4	GlucocorticoidsIBA 01/2021 - 01/2017
3	EnzymesIBA 03/2022 - 10/2021
2	tocilizumab (atlizumab)FDA Link 03/2021 - 12/2017
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 12/2020 - 01/2016
2	Rituximab (Mabthera)FDA Link 12/2020 - 01/2020
2	Methotrexate (Mexate)FDA LinkGeneric 03/2020 - 01/2019
2	Biological ProductsIBA 11/2018 - 07/2017
1	pexidartinibIBA 01/2022
1	ruxolitinibIBA 01/2022
1	Janus Kinase InhibitorsIBA 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	Codon (Codons)IBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	HaptoglobinsIBA 01/2022
1	NucleotidesIBA 01/2022
1	Phenobarbital (Luminal)FDA Link 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2022
1	Mitogen-Activated Protein KinasesIBA 01/2022
1	Ubiquitin-Activating Enzymes (Ubiquitin-Activating Enzyme)IBA 01/2022
1	Janus Kinase 3IBA 01/2022
1	baricitinibIBA 01/2022
1	AutoantibodiesIBA 01/2021
1	Cladribine FDA LinkGeneric 01/2021
1	VemurafenibIBA 11/2020
1	SteroidsIBA 05/2020
1	LipidsIBA 11/2017
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2017
1	Dihydrotachysterol (AT 10)IBA 01/2017
1	GTP-Binding Proteins (G-Protein)IBA 07/2006
1	Heterotrimeric GTP-Binding Proteins (Heterotrimeric G-Proteins)IBA 07/2006
1	GTP Phosphohydrolases (GTPases)IBA 07/2006